• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CTE 4.82% 87.0¢

CRYOSITE LIMITED

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The... Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CTE 23/02/24 0 199
23/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  199 
CTE 23/02/24 0 108
23/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  108 
CTE 22/02/24 0 194
22/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  194 
CTE 22/02/24 0 300
22/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  300 
CTE 16/02/24 0 266
16/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
CTE 15/02/24 0 142
15/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  142 
CTE 25/01/24 0 168
25/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  168 

See All Discussions arrow Created with Sketch.

Timeline

Initial Director's Interest Notice - Andrew Kerr
23 Feb 11:19
 
Final Director's Interest Notice - John Hogg
23 Feb 11:16
 
Board Changes
22 Feb 19:01
 
Appendix 4D and Half Year Accounts
22 Feb 17:53
 
Confirmation of record date for capital return
16 Feb 15:54
 
General Meeting Results
15 Feb 13:34
 
View More arrow Created with Sketch.
(20min delay)
Last
87.0¢
Change
0.040(4.82%)
Mkt cap ! $42.46M
Open High Low Value Volume
83.0¢ 87.0¢ 83.0¢ $39.28K 46.68K

Buyers (Bids)

No. Vol. Price($)
1 2300 85.0¢
 

Sellers (Offers)

Price($) Vol. No.
87.0¢ 21564 1
View Market Depth
Last trade - 15.53pm 25/04/2024 (20 minute delay) ?
CTE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.